Brad Hightower

Brad Hightower, owner of Hightower Clinical, dives into the challenges of balancing technology with clinical trial efficiency. He discusses whether the increasing tech burden is justified for progress and shares insights on how sponsors can ease site operations. The conversation highlights the implications of recent FDA guidance on decentralized trials and the importance of fostering communication between sites and sponsors. Brad also teases the upcoming ‘Save Our Sites’ conference aimed at revolutionizing site support.